From the Journals

Few poorly prepped colonoscopies repeated within 1 year


 

FROM GASTROINTESTINAL ENDOSCOPY

Get the word out on describing preps and planning follow-ups

The current study is important because it highlights that, even when endoscopists have a reasonable understanding on how to set follow-up intervals for polyp follow-up, what to do with a patient who comes in poorly prepped is more of a problem, Kim L. Isaacs, MD, of the University of North Carolina at Chapel Hill, said in an interview.

Dr Isaacs said she was not surprised by the study findings. “There are all gradations of inadequate preps that limit visualization in different ways, and there are many ways of recording this on procedure reports. The findings in the current study emphasize several points. The first is that the recommendation of following up an inadequate or poor prep in a year needs to be widely disseminated. The second is that there needs to be more education on standardization on how preps are described. In some poor preps, much of the colon can be seen, and clinicians can identify polyps 5-6 mm, so a 1-year follow-up may not be needed.” This type of research is challenging if the data are not standardized, she added.

Dr. Isaacs agreed with the authors’ description of repeat colonoscopies after poor bowel prep as a quality improvement area given the variability in following current recommendations, which leads into next steps for research.

“Understanding reasons for the recommendations that endoscopists made for follow-up would be the next step in this type of research,” Dr Isaacs noted. “After that, studies on the impact of an educational intervention, followed by repeating the initial assessment.”

The study received no outside funding. The researchers had no financial conflicts to disclose; however, lead author Dr. Calderwood disclosed support from the National Cancer Institute, the Dartmouth-Hitchcock Cancer Research Fellows Program, the Dartmouth-Hitchcock Norris Cotton Cancer Center, and the Dartmouth Clinical and Translational Science Institute. Dr Isaacs had no financial conflicts to disclose but has previously served on the editorial board of GI & Hepatology News.

Pages

Recommended Reading

Gut microbiome could make weight loss easier for some
MDedge Family Medicine
Gastric cancer: Family history–based H. pylori strategy would be cost effective
MDedge Family Medicine
Nutritious meals, more fruits and vegetables boost children’s mental and emotional health
MDedge Family Medicine
Acceptance of biosimilars grows but greater use may hinge on switching, interchangeability studies
MDedge Family Medicine
Extraesophageal symptoms of GERD 
MDedge Family Medicine
UC relapse associated with impaired luminal control of macrophage maturation
MDedge Family Medicine
Rivaroxaban’s single daily dose may lead to higher bleeding risk than other DOACs
MDedge Family Medicine
GERD: Composite pH impedance monitoring better identifies treatment escalation need
MDedge Family Medicine
AGA Clinical Practice Update: Expert review on GI perforations
MDedge Family Medicine
Adalimumab biosimilar Cyltezo gets interchangeability designation
MDedge Family Medicine